Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Blocking mitochondrial calcium release in Schwann cells prevents demyelinating neuropathies.
Intensity of treadmill walking exercise on acute mood symptoms in persons with multiple sclerosis.
Clinical characteristics of intermediate uveitis in adult Turkish patients.
Living well with multiple sclerosis.
SOCS1 Mimetics and Antagonists: A Complementary Approach to Positive and Negative Regulation of Immune Function.
Changes in Methionine Metabolism and Histone H3 Trimethylation Are Linked to Mitochondrial Defects in Multiple Sclerosis.
Guillain-Barre syndrome following dengue fever and literature review.
Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies.
Cause and prevention of demyelination in a model multiple sclerosis lesion.
Tumefactive multiple sclerosis requiring emergency craniotomy: Case report and literature review.
Soluble Tumor Necrosis Factor Receptor 1 Released by Skin-Derived Mesenchymal Stem Cells Is Critical for Inhibiting Th17 Cell Differentiation.
Multiple sclerosis: Daclizumab HYP shows efficacy in patients with relapsing-remitting MS.
Dextromethorphan/Quinidine for the treatment of pseudobulbar affect.
Alterations in Functional and Structural Connectivity in Pediatric-Onset Multiple Sclerosis.
Targeting the 18-kDa translocator protein: recent perspectives for neuroprotection.
MHC Class II Polymorphisms, Autoreactive T-Cells, and Autoimmunity.
Cutting Edge: Nanogel-Based Delivery of an Inhibitor of CaMK4 to CD4+ T Cells Suppresses Experimental Autoimmune Encephalomyelitis and Lupus-like Disease in Mice.
Long-term assessment of No Evidence of Disease Activity with natalizumab in relapsing multiple sclerosis.
Ultrahigh field MRI in clinical neuroimmunology: a potential contribution to improved diagnostics and personalised disease management.
Mesenchymal stem cells require the peripheral immune system for immunomodulating effects in animal models of multiple sclerosis.
Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis?
Impaired functional integration in multiple sclerosis: a graph theory study.
Lesion Expansion in Experimental Demyelination Animal Models and Multiple Sclerosis Lesions.
Effect of vitamin D status on pharmacological treatment efficiency: Impact on cost-effective management in medicine.
Kaposi sarcoma in a patient with relapsing-remitting multiple sclerosis receiving fingolimod.
Pages
« first
‹ previous
…
540
541
542
543
544
545
546
547
548
…
next ›
last »